Box score
Outpace Bio, Inc.
Reported $56M sold in a new Form D filed August 1, 2024 (Seattle, Washington).
- Biggest raise
- $56M filed Aug 1, 2024
- League
- Bio & Health Biotechnology
- Based in
- Seattle, Washington
- Season rank
- #89 of 1,389 in the Bio & Health League; #347 of 12,443 overall (2024)
- Incorporated
- 2020
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-08-01 | New notice | $56M | $144M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2031531.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Perspective Therapeutics, Inc. | Bio & Health | $87.4M |
| 2 | RIPPL Care, Inc. rookie | Bio & Health | $23M |
| 3 | Freespira, Inc. | Bio & Health | $22.6M |
| 4 | Perspective Therapeutics, Inc. | Bio & Health | $20.8M |
| 5 | Blaze Bioscience, Inc. | Bio & Health | $8.1M |
| 6 | Accipiter Biosciences Inc. | Bio & Health | $7.9M |